Tenax Therapeutics, Inc. · NASDAQ:TENX
Ikarian Capital, LLC reported a 15.50% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)
Event Nov 30, 2025 · Filed Dec 5, 2025
Ikarian Capital, LLC reported a 15.50% stake in Tenax Therapeutics, Inc., 967,600 shares, as a passive investor on Nov 30, 2025. Filed Dec 5, 2025 (Schedule 13G/A).
- Stake
- 15.50%
- Shares
- 967,600
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 15.50% | 967,600 |
| Neil Shahrestani | 15.50% | 967,600 |
Source
Related
- Tenax Therapeutics, Inc.
- Ikarian Capital, LLC
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Apr 7, 2026
- Schedule 13G · Ikarian Capital, LLC · Oct 7, 2025
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026